Skip to main navigation

>> Site Menu

  • Our Company
  • Our Science
  • Our Products
  • Our Culture
  • INVESTORS & MEDIA
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • ESG Report
    • Investor Resources
Kodiak Sciences

>> Site Menu

  • Our Company
  • Our Science
  • Our Products
  • Our Culture
  • INVESTORS & MEDIA
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • ESG Report
    • Investor Resources

News Releases

> News - Sub Nav

  • Press Releases

News Releases

March 28, 2023
Kodiak Sciences Announces Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
Additional Formats
PDF Version
February 9, 2023
Kodiak Sciences Announces Upcoming Presentation of KSI-301 (tarcocimab tedromer) Clinical Data and Antibody Biopolymer Conjugate Development Programs at the Angiogenesis, Exudation and Degeneration 2023 Virtual Meeting
Additional Formats
PDF Version
January 4, 2023
Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Additional Formats
PDF Version
 
 
 
Disclaimer

Some of the statements on this site are forward-looking. Such statements are inherently subject to known as well as unknown risks and uncertainties, including scientific, business, economic and financial factors and other factors that may cause actual results, performance or achievements of Kodiak Sciences to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements speak only as of the date they are posted to this website (unless an earlier date is indicated). Kodiak Sciences does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Kodiak’s drug candidates are investigational compounds in development and have not received regulatory approval in any country.

KODIAK SCIENCES INC.

1200 Page Mill Road
Palo Alto, CA 94304
United States of America

Kodiak Sciences GMBH
Dammstrasse 19
6300 ZUG
Switzerland

info@kodiak.com

Kodiak Sciences Valais GMBH
Rottenstrasse 5
3930 VISP
Switzerland

LinkedIn Twitter
Copyright © 2023 Kodiak Sciences Inc.